Transcriptomic analyses indicate that KDM6A-mutant bladder cancers have downregulation of multiple interferon and chemokine signaling pathways required for effective tumor immunity (Kobatake et al., 2020). This evidence concerns the gene KDM6A and urinary bladder cancer.